{"id":60750,"title":"Time has come for immunotherapy in PTCL.","abstract":"In this issue of Blood, Horwitz et al present encouraging results of a phase 2 study assessing the efficacy of the antibody-drug conjugate (ADC) brentuximab vedotin (BV) in relapsed/refractory peripheral T-cell lymphoma (PTCL).","date":"2014-05-16","categories":"Hemic and Lymphatic Diseases","split":"test","url":"http://www.ncbi.nlm.nih.gov/pubmed/24832935","annotations":[{"name":"Clinical trial","weight":0.136645,"wikipedia_article":"http://en.wikipedia.org/wiki/Clinical_trial"},{"name":"Immunotherapy","weight":0.0297972,"wikipedia_article":"http://en.wikipedia.org/wiki/Immunotherapy"},{"name":"Brentuximab vedotin","weight":0.0297972,"wikipedia_article":"http://en.wikipedia.org/wiki/Brentuximab_vedotin"},{"name":"Lymphoma","weight":0.0239124,"wikipedia_article":"http://en.wikipedia.org/wiki/Lymphoma"},{"name":"Blood","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Blood"},{"name":"Grammatical conjugation","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Grammatical_conjugation"},{"name":"Peripheral nervous system","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Peripheral_nervous_system"},{"name":"Time (magazine)","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Time_(magazine)"},{"name":"Drug metabolism","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Drug_metabolism"},{"name":"Horwitz","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Horwitz"},{"name":"Besloten Vennootschap","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Besloten_Vennootschap"},{"name":"Efficacy","weight":0.0157947,"wikipedia_article":"http://en.wikipedia.org/wiki/Efficacy"},{"name":"Aide-de-camp","weight":0.0152478,"wikipedia_article":"http://en.wikipedia.org/wiki/Aide-de-camp"},{"name":"Phase (matter)","weight":0.0147415,"wikipedia_article":"http://en.wikipedia.org/wiki/Phase_(matter)"}]}
